Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas J Baltz"'
Autor:
Natalia Colorado, Peter D. Emanuel, Delli Robinson, Yuqing Liu, Erich A. Peterson, Donald J. Johann, Daohong Zhou, Alice Bertaina, Nitza Vara, Nicholas J. Baltz, Shelly Lensing, Jingliao Zhang, Yan Yan, Y. Lucy Liu, Xin Zhang
Publikováno v:
Blood Adv
It is not clear whether disrupted age-specific hematopoiesis contributes to the complex manifestations in leukemia patients who carry identical mutations, particularly in pediatric and adult patients with similar clinical characteristics. By studying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b12c4c51b6b0995f7f7fd539ad17a1
https://europepmc.org/articles/PMC7422126/
https://europepmc.org/articles/PMC7422126/
Autor:
Jingliao Zhang, Yan Yan, Nicholas J. Baltz, Peter D. Emanuel, Y. Lucy Liu, Priyangi A. Malaviarachchi, Zhifu Xiang
Publikováno v:
Cellular signalling. 50
Constitutively activated MAPK and AKT signaling pathways are often found in solid tumors and leukemias. PTEN is one of the tumor suppressors that are frequently found deficient in patients with late-stage cancers or leukemias. In this study we demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faab8c17074b42fe9fb3efc4809e9848
https://pubmed.ncbi.nlm.nih.gov/29964149
https://pubmed.ncbi.nlm.nih.gov/29964149
Autor:
Nicholas J. Baltz, Delli Robinson, Yan Yan, Y. Lucy Liu, Natalia Colorado, Shelly Lensing, Peter D. Emanuel, Daohong Zhou
Publikováno v:
Blood. 128:1550-1550
Juvenile myelomonocytic leukemia (JMML) and chronic myelomonocytic leukemia (CMML) are mixed myelodysplastic syndromes (MDS)/myeloproliferative neoplasms (MPNs) that share similar clinical manifestations, but differ in prognosis and ages at diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e4d838f39a6de43d0fc541ef51fe877
https://doi.org/10.1182/blood.v128.22.1550.1550
https://doi.org/10.1182/blood.v128.22.1550.1550
Autor:
Shelly Lensing, Yan Yan, Jason E. Farrar, Peter D. Emanuel, Natalia Colorado, Y. Lucy Liu, Delli Robinson, Michele Cottler-Fox, Nicholas J Baltz
Publikováno v:
Blood. 128:5899-5899
Acute myeloid leukemia (AML) is a hematologic malignancy that continues to have high relapse and treatment-related mortality rates, despite recent advances in clinical management and therapy. Janus kinase (JAK) inhibitors inhibit the activity of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88626e92e4069d04f2748f2d76ed3328
https://doi.org/10.1182/blood.v128.22.5899.5899
https://doi.org/10.1182/blood.v128.22.5899.5899